In the Case in the Text,ProMedica Health System,Inc

In the case in the text,ProMedica Health System,Inc.v.Federal Trade Commission,the court held that:

A) the Commission erred when it ordered divestiture as the remedy.
B) the merger would not be substantially anticompetitive.
C) the Commission could not put significant weight on the market-concentration data alone.
D) the merger would reduce competition in violation of the Clayton Act.